期刊文献+

静脉应用蔗糖铁与口服硫酸亚铁治疗肾性贫血疗效比较 被引量:6

下载PDF
导出
摘要 目的:比较静脉滴注蔗糖铁注射液与口服硫酸亚铁片治疗慢性肾功能衰竭尿毒症期行维持性血液透析患者肾性贫血的有效性与安全性。方法:将60例行维持性血液透析治疗的慢性肾衰患者随机分为蔗糖铁组和硫酸亚铁组,每组30例。两组患者均联合促红细胞生成素(EPO)治疗,治疗12周后观察患者血红蛋白(Hb)、红细胞(RBC)、红细胞压积(Hct)、血清铁蛋白(SF)、转铁蛋白饱和度(TSAT)等相关指标的变化,同时观察治疗中的不良反应。结果:经过相应治疗后两组的血红蛋白、红细胞、红细胞压积、血清铁蛋白、转铁蛋白饱和度与治疗前比较,均有增高,差异有统计学意义(P<0.05);但经过治疗后蔗糖铁组的血红蛋白、红细胞、红细胞压积、血清铁蛋白、转铁蛋白饱和度明显高于硫酸亚铁组,差异有统计学意义(P<0.05)。蔗糖铁组副作用发生少。结论:与口服硫酸亚铁比较,静脉应用蔗糖铁更有效补充肾性贫血所需的铁剂,安全性好。
出处 《河北医学》 CAS 2014年第8期1359-1361,共3页 Hebei Medicine
  • 相关文献

参考文献10

  • 1Portoles J, Lopez- Comez JM, Aljama P. On behalf of the MAR study group. A prospective multicentre study of the role of anaemia as arisk factor in haetnodialysis patients: the MAR study[ J ].Nephrol DialTransplant, 2007,22 (4) : 500-507.
  • 2Ware RE, Rees RC, Sarnaik SA, et al. Renal function in in- fants with sickle cell Anemia: baseline data from the baby HUG trial[J] .The Journal of Pediatrics, 2010,156( 1 ) :66- 70.
  • 3Lankhorst CE,Wish JB. Anemia in renal disease: diagnosis and management[ J].Blood Rev,2010,24(1) :39-47.
  • 4钟莉慧.蔗糖铁治疗肾性贫血患者40例效果观察[J].临床合理用药杂志,2011,4(16):76-76. 被引量:3
  • 5王海燕.肾脏病学[M]人民卫生出版社.1998.865.
  • 6威廉L.亨里奇透析原理与实践[M].辽宁科学技术出版社,2007.511.
  • 7王海燕.肾脏病学[M].北京:人民卫生出版社,2008:1948-1949.
  • 8王蕴若,陈茂杰,王惠新.静脉铁剂治疗维持性血液透析患者肾性贫血的疗效分析[J].实用临床医药杂志,2010,14(6):67-68. 被引量:9
  • 9Fudin R, Jaichenko J, Shostak A, et al. Correction of ure- mic irondeficiency anemia in hemodialyzed patients: a pro- spective study[J].Nephron, 1998,79(3) :299.305.
  • 10潘健涛,朱波,蔡宗仰,邓会芬,周风婵,赵志权.蔗糖铁佐治血液透析患者肾性贫血[J].新医学,2002,33(3):158-159. 被引量:8

二级参考文献8

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:710
  • 2王海燕.肾脏病学(第2版)[M].北京:人民卫生出版社,1998.1385.
  • 3National Kidney Foundation,NKF-K/DOQI Clinical Practice Guidelines for Anemia of chronic kidney disease:update 2000[J].Am J KIDNEY Dis,2001,37(1 suppl 1):S182.
  • 4Macdougall IC,Horl WH,Jacobs C,et al.European Best Practice Guidelines6-8:assessing and optimizing iron stores[J].Nephrol Dial Transplant,2000,15(Suppl 4):20.
  • 5Muirhead N, Bergman J, Burgess E, et al. Evidence- based recommend- ations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis, 1995, 26 (Suppl 1): 1- 4.
  • 6Gazzda M, Ponchin L, Beguiny, et al. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders: results of a phase Ⅰ /Ⅱ clinical trial. Blood, 1992, 79 (1): 29- 30.
  • 7NKF-K/DOQI慢性肾脏病贫血治疗的临床实践指南[J].中国血液净化,2007,6(9):507-516. 被引量:17
  • 8路必琼,刘惠凤,蔡伟文,朱颖,赵艳君,王翠,毛莹珏.老年病人使用浅静脉留置针的血管选择[J].护理学杂志(综合版),2003,18(2):91-92. 被引量:139

共引文献260

同被引文献47

  • 1陈云亮,钱伯初,王根才,刘朝胜.生血宁片治疗贫血模型鼠的实验研究[J].湖北中医学院学报,2005,7(1):11-13. 被引量:20
  • 2Tsagalis G. Renal anemia: a nephrologist's view[J]. Hipp- okratia, 2011, 15(Suppl 1): 39-43.
  • 3Bolin TD. Investigating iron deficiency anaemia[J]. Med J Aust, 2014, 200(1): 17-18.
  • 4Garlo K, Williams D, Lucas L, et al. Severity of Anemia Pre- dicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study FJ]. Medicine (Baltimore), 21)15, 94(25)t e964.
  • 5Valderrabano F. Anaemia management in chronic kidney dis- ease patients: an overview of current clinical practice [J]. Nephrol Dial Transplant, 2002, 17 Suppl 1: 13-18.
  • 6Potthoff SA, Munch HG. Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney dis- ease[J-]. Dtsch Med Woehenschr, 2013, 138(24) : 1312-1317.
  • 7Tsuchida A, Paudyal B, Paudyal P, et al. Effectiveness of o- ral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate[J]. Exp Ther Med, 2010, 1(5): 777-781.
  • 8徐文君,吴国伟,郑卫华,等.生血宁片治疗慢性肾脏病非透析患者肾性贫血的临床观察[z].中国浙江杭州:2014.
  • 9陈运彬,王艳丽,高薇薇.生血宁片联合促红细胞生成素治疗早产儿贫血60例临床研究[J].广州中医药大学学报,2009,26(1):28-31. 被引量:7
  • 10孙丙政,王云峰,黄聪,郭延红,杜薇.口服补铁剂及多糖铁络合物的研究进展[J].微量元素与健康研究,2009,26(5):64-67. 被引量:13

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部